Found: 120
Select item for more details and to access through your institution.
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 92, doi. 10.1007/s10637-019-00804-5
- By:
- Publication type:
- Article
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 709, doi. 10.1007/s10637-018-0579-8
- By:
- Publication type:
- Article
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 760, doi. 10.1007/s10637-016-0385-0
- By:
- Publication type:
- Article
Dedicated supportive care team at the oncology unit: a model of simultaneous care for cancer patients.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Supportive care and not only palliative care in the route of cancer patients.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.
- Published in:
- Scientific Reports, 2015, p. 18670, doi. 10.1038/srep18670
- By:
- Publication type:
- Article
Androgen receptor (AR) splice variant 7 and full‐length AR expression is associated with clinical outcome: a translational study in patients with castrate‐resistant prostate cancer.
- Published in:
- BJU International, 2019, v. 124, n. 4, p. 693, doi. 10.1111/bju.14792
- By:
- Publication type:
- Article
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193640
- By:
- Publication type:
- Article
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 100, doi. 10.1016/j.clcc.2022.11.002
- By:
- Publication type:
- Article
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 314, doi. 10.1016/j.clcc.2021.07.001
- By:
- Publication type:
- Article
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 191, doi. 10.1016/j.clcc.2020.03.009
- By:
- Publication type:
- Article
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Adjuvant Systemic Chemotherapy After Putative Curative Resection of Colorectal Liver and Lung Metastases.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 188, doi. 10.1016/j.clcc.2013.04.002
- By:
- Publication type:
- Article
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 4, p. 384, doi. 10.1016/j.clpt.2006.06.007
- By:
- Publication type:
- Article
Reply.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 5, p. 507, doi. 10.1016/j.clpt.2004.07.015
- By:
- Publication type:
- Article
Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 6, p. 627, doi. 10.1067/mcp.2002.128867
- By:
- Publication type:
- Article
Cholinergic toxic syndrome by the anticancer drug irinotecan: Acetylcholinesterase does not play a major role.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 4, p. 263, doi. 10.1067/mcp.2002.121909
- By:
- Publication type:
- Article
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39525-3
- By:
- Publication type:
- Article
In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3775, doi. 10.3390/ijms23073775
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1658, doi. 10.3390/ijms21051658
- By:
- Publication type:
- Article
The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 8, p. 2298, doi. 10.3390/ijms19082298
- By:
- Publication type:
- Article
VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.
- Published in:
- International Journal of Colorectal Disease, 2009, v. 24, n. 2, p. 165, doi. 10.1007/s00384-008-0586-x
- By:
- Publication type:
- Article
Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 1, p. 21, doi. 10.1093/jnci/djq456
- By:
- Publication type:
- Article
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients.
- Published in:
- Oncology Research, 2020, v. 28, n. 6, p. 631, doi. 10.3727/096504020X16056983169118
- By:
- Publication type:
- Article
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.
- Published in:
- Cancer & Metastasis Reviews, 2012, v. 31, n. 3/4, p. 753, doi. 10.1007/s10555-012-9387-3
- By:
- Publication type:
- Article
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 1, p. 57, doi. 10.1007/s10549-019-05365-y
- By:
- Publication type:
- Article
Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients.
- Published in:
- Oncology, 2016, v. 91, n. 6, p. 311, doi. 10.1159/000443962
- By:
- Publication type:
- Article
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
- Published in:
- Oncology, 2016, v. 91, n. 5, p. 283, doi. 10.1159/000448004
- By:
- Publication type:
- Article
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 75, doi. 10.1159/000329079
- By:
- Publication type:
- Article
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/dju427
- By:
- Publication type:
- Article
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Biochemical Modulation by 5-Fluorouracil and 1-Folinic Acid of Tumor Uptake of Intra-Arterial 5-[<sup>123</sup>I]Iodo-2'-Deoxyuridine in Patients with Liver Metastases from Colorectal Cancer.
- Published in:
- Acta Oncologica, 1996, v. 35, n. 7, p. 941, doi. 10.3109/02841869609104049
- By:
- Publication type:
- Article
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 493, doi. 10.1007/s00432-019-03077-w
- By:
- Publication type:
- Article
Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients.
- Published in:
- Clinical & Experimental Medicine, 2021, v. 21, n. 1, p. 149, doi. 10.1007/s10238-020-00666-9
- By:
- Publication type:
- Article
Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2019, v. 29, p. e1911750, doi. 10.1001/jamanetworkopen.2019.11750
- By:
- Publication type:
- Article
FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642
- By:
- Publication type:
- Article
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. 886, doi. 10.1634/theoncologist.2019-0922
- By:
- Publication type:
- Article
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 8, p. 988, doi. 10.1634/theoncologist.2016-0084
- By:
- Publication type:
- Article
High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease.
- Published in:
- Oncologist, 2012, v. 17, n. 6, p. 823, doi. 10.1634/theoncologist.2012-0081
- By:
- Publication type:
- Article
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice.
- Published in:
- Oncologist, 2008, v. 13, n. 12, p. 1270, doi. 10.1634/theoncologist.2008-0181
- By:
- Publication type:
- Article